Hi, you are logged in as , if you are not , please click here
You are shopping as , if this is not your email, please click here

F47 MBI: Vaccine Bioprocess Development & Commercialisation 2026

Info
Location
Contact

Event Information

Vaccines
Dates of Event
2nd June 2026 – 4th June 2026
Last Booking Date for this Event
1st June 2026

Description

The course is designed to explore the critical issues at each stage of vaccine development. Attendees hear from international experts about the research as well as operational and regulatory challenges facing the global vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about strategies for commercial specifications for vaccines.

 

Topics covered will include:

Introduction to Vaccine Development with Case Studies

Scale-up from lab to pilot scale

Quality by Design (QbD) as part of vaccine development

Expression systems

Single use platforms

Process Development Challenges of Novel Vaccines

Adventitious Agent Contamination in Biomanufacturing

Final formulation and adjuvants

Regulatory Perspectives and Future Directions

Global Vaccine Preparedness to Respond to Future Disease Outbreaks

 

The cost of the course includes tuition, course materials, lunches, refreshments and a networking dinner. Accommodation is not included.

Attendee CategoryCost   
Standard.£2250.00[Read More]

How would you rate your experience today?

How can we contact you?

What could we do better?

   Change Code